Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
7.13
-0.32 (-4.32%)
At close: May 12, 2025, 4:00 PM
7.82
+0.69 (9.71%)
After-hours: May 12, 2025, 7:45 PM EDT
Liminatus Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 0.53 | 1.06 | 0.86 |
| Research & Development | 3.4 | 3.76 | 1.85 |
| Operating Expenses | 3.93 | 4.82 | 2.71 |
| Operating Income | -3.93 | -4.82 | -2.71 |
| Interest Expense | -0.25 | -0.18 | -0.22 |
| Interest & Investment Income | 0.09 | 0.01 | - |
| Pretax Income | -4.09 | -4.98 | -2.93 |
| Net Income | -4.09 | -4.98 | -2.93 |
| Net Income to Common | -4.09 | -4.98 | -2.93 |
| Shares Outstanding (Basic) | 112 | 102 | 36 |
| Shares Outstanding (Diluted) | 112 | 102 | 36 |
| Shares Change (YoY) | - | 188.25% | - |
| EPS (Basic) | -0.04 | -0.05 | -0.08 |
| EPS (Diluted) | -0.04 | -0.05 | -0.08 |
| EBIT | -3.93 | -4.82 | -2.71 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.